MedPath

The Effects of Zonisamide on Alcohol Dependence

Phase 2
Completed
Conditions
Alcoholism
Interventions
Registration Number
NCT00406692
Lead Sponsor
Boston University
Brief Summary

In this study the influence of zonisamide administration over a 13 week period on alcohol consumption in alcoholic (alcohol dependent) subjects will be examined. The dose of zonisamide given to subjects will be slowly increased over a period of several weeks. They will receive a full dose over a 5 week period. This will be a pilot study in which all of the subjects will only receive zonisamide. A primary objective of this study is to determine the possible size of the effect that zonisamide administration has on drinking (i.e. drinks consumed per day) to allow us to plan for a larger clinical trial of the effects of zonisamide on alcohol dependence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ZonisamideZonisamideIn open-label non-placebo controlled trial subjects are treatment with zonisamide 400 mg during the maintenance phase of this study
Primary Outcome Measures
NameTimeMethod
The Weekly Mean Number of Standard Drinks Consumed Per Day at Baseline and Treatment PhaseBaseline and Week 12

The mean daily standard alcoholic drinks were determined for the baseline period and each treatment week as a measure of alcohol intake. One standard drink=14g of alcohol. Mean value is the difference between mean standard drinks for the baseline period and week 12 of the study.

Difference in Mean Words for the Phonetic Portion of the Controlled Word Association Test (COWAT).Week 0- Baseline and Week 12

Subjects were asked to generate as many words as possible starting with a particular letter over a 60 second period. Three letters were used for each sessions. Values shown are the differences between values obtained for the baseline and week 12 test session.

Secondary Outcome Measures
NameTimeMethod
Symbol Digit Modalities Test (DSMT)Baseline, Week 12

Number of correct digit substitutions on the DSMT per session with the possible maximum score being 188. The value shown is for difference between mean scores obtained for baseline and week 12 sessions.

Trial Locations

Locations (1)

Boston University School of Medicine

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath